The VENTANA DLL3 (SP347) Assay is an immunohistochemistry assay utilizing a rabbit monoclonal antibody that can be used to identify patients that may potentially respond to DLL3 targeted therapies. It can precisely evaluate DLL3 expression in FNA SCLC samples.